Previous Close | 195.11 |
Open | 198.07 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1000 |
Day's Range | 195.56 - 198.60 |
52 Week Range | 161.65 - 275.00 |
Volume | |
Avg. Volume | 732,812 |
Market Cap | 10.212B |
Beta (5Y Monthly) | 1.36 |
PE Ratio (TTM) | 23.69 |
EPS (TTM) | 8.35 |
Earnings Date | Nov 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 209.95 |
WILMINGTON, Mass., October 17, 2024--Charles River launches the Retrogenix® Non-Human Protein Library to support assessment of off-target binding, de-risk studies & aid model selection.
WILMINGTON, Mass., October 16, 2024--Charles River Laboratories schedules third-quarter 2024 earnings release and conference call.